To Evaluate the Pharmacokinetics (PK) and Safety of Tavapadon in Participants With Mild and Moderate Hepatic Impairment Compared to Participants With Normal Hepatic Function
Clinical trial NCT05404529 · COMPLETED
Trial details
- NCT number
- NCT05404529
- Sponsor
- Cerevel Therapeutics, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-29
- Primary completion
- 2023-01-24
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.